Technical Analysis for ACL - Australian Clinical Labs Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.225 | 1.14% | 0.025 |
ACL closed up 1.85 percent on Wednesday, May 29, 2024, on 1.43 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Low | Weakness | 1.14% | |
| Outside Day | Range Expansion | 1.14% | |
| Oversold Stochastic | Weakness | 1.14% | |
| New 52 Week Closing Low | Bearish | 3.01% | |
| 180 Bearish Setup | Bearish Swing Setup | 3.01% | |
| Lower Bollinger Band Walk | Weakness | 3.01% | |
| Hammer Candlestick | Bullish | 0.68% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.68% | |
| Doji - Bullish? | Reversal | 0.68% | |
| Lower Bollinger Band Walk | Weakness | 0.68% |
| Alert | Time |
|---|---|
| Up 1% | 3 minutes ago |
| Fell Below Previous Day's Low | about 2 hours ago |
| New 52 Week Low | about 2 hours ago |
| 2x Volume Pace | about 2 hours ago |
| Down 2% | about 2 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Australian Clinical Labs Limited provides pathology services. The company offers all routine pathology tests, advanced pathology, first trimester screening and non-invasive prenatal testing, chemical pathologand, haematology, histopathology, immunology, serology and microbiology, functional pathology, and commercial drug and alcohol testing services. It also offers COVID-19, testing guide, GP services, and specialists services. The company offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 1987 and is based in Clayton, Australia. Clinical Laboratories Pty Ltd operates as a subsidiary of Healthscope Group.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Health Care Pathology Pathology Services Prenatal Testing
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Health Care Pathology Pathology Services Prenatal Testing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.4276 |
| 52 Week Low | 2.145 |
| Average Volume | 491,254 |
| 200-Day Moving Average | 2.695 |
| 50-Day Moving Average | 2.466 |
| 20-Day Moving Average | 2.360 |
| 10-Day Moving Average | 2.259 |
| Average True Range | 0.070 |
| RSI (14) | 32.89 |
| ADX | 30.92 |
| +DI | 12.382 |
| -DI | 29.040 |
| Chandelier Exit (Long, 3 ATRs) | 2.339 |
| Chandelier Exit (Short, 3 ATRs) | 2.356 |
| Upper Bollinger Bands | 2.597 |
| Lower Bollinger Band | 2.122 |
| Percent B (%b) | 0.16 |
| BandWidth | 20.123 |
| MACD Line | -0.081 |
| MACD Signal Line | -0.062 |
| MACD Histogram | -0.0187 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.343 | ||||
| Resistance 3 (R3) | 2.340 | 2.290 | 2.319 | ||
| Resistance 2 (R2) | 2.290 | 2.254 | 2.291 | 2.311 | |
| Resistance 1 (R1) | 2.245 | 2.231 | 2.268 | 2.248 | 2.303 |
| Pivot Point | 2.195 | 2.195 | 2.206 | 2.196 | 2.195 |
| Support 1 (S1) | 2.150 | 2.159 | 2.173 | 2.153 | 2.097 |
| Support 2 (S2) | 2.100 | 2.136 | 2.101 | 2.089 | |
| Support 3 (S3) | 2.055 | 2.100 | 2.081 | ||
| Support 4 (S4) | 2.058 |
